Aclaris Therapeutics(ACRS) - 2023 Q1 - Earnings Call Transcript

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2023 Earnings Conference Call May 8, 2023 8:00 AM ET Company Participants Robert Doody - Head of Investor Relations Douglas Manion - Chief Executive Officer Gail Cawkwell - Senior Key Executive Joseph Monahan - Chief Scientific Officer Kevin Balthaser - Chief Financial Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Corinne Jenkins - Goldman Sachs Thomas Smith - SVB Securities Alexander Thompson - Stifel Roger Song - Jefferies Dipesh Patel - W ...